We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 25,850

Increase Proposed for Mississippi’s “Tobacco Equity Tax”
  • Troutman Sanders LLP
  • USA
  • January 17 2018

Pending before the Mississippi Legislature is House Bill 906, which, if enacted, would increase the “tobacco equity tax” applicable to cigarettes

  • Uchida & Samejima Law Firm
  • Japan
  • January 16 2018


FDA Proposes to Delay Off-Label “Intended Use” Rule
  • Reed Smith LLP
  • USA
  • January 16 2018

Perhaps you have heard that elections have consequences. That is true not only for high-profile issues that hog the headlines on CNN and Fox News, but

3D Printing Meets Medical Devices: FDA Weighs In On Additive Manufacturing
  • Morrison & Foerster LLP
  • USA
  • January 16 2018

In December, the U.S. Food and Drug Administration (FDA) issued guidance on Technical Considerations for Additive Manufactured Medical Devices. The

Surveys Seal the Deal in Defeating Starbucks and 5 Hour Energy Class Actions
  • Crowell & Moring LLP
  • USA
  • January 16 2018

Surveys play an increasingly important role in consumer class actions, whether used to deny class certification, defeat plaintiffs’ allegations of

Reading Between the Blurred Lines
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • January 16 2018

The Federal Trade Commission recently released a Staff Report regarding consumer recognition of native and search advertising entitled “Blurred Lines”

CE Marking Post-Brexit
  • Squire Patton Boggs
  • United Kingdom, European Union
  • January 16 2018

On 10 January 2018, the European Commission published important notice warning of the consequences that Brexit will have in the field of industrial

Is Nurofen better than Panadol for a headache? The Federal Court decides
  • Cordato Partners
  • Australia
  • January 15 2018

When one medicine is advertised as being more effective than another, the Court examines the scientific studies to decide if they support the

New Danish self-selection system for over-the-counter medicines
  • Accura Advokatpartnerselskab
  • Denmark
  • January 15 2018

On 1 January 2018, a new system for self-selection of over-the-counter (OTC) medicines came into force in Denmark. The new system allows for certain